Carcinoma, NeuroendocrineFase 2NCT06406465
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
Belinostat, Cisplatin, Etoposide
12 estudios de fase 2 reclutando ahora mismo, los actualizados más recientemente primero.
Abrir la página de fase 2 · una lista solo de esos estudios
Triangle is made by Triangle Health, Inc.
Tiroides y neuroendocrinos12 estudios
Carcinoma, NeuroendocrineFase 2NCT06406465
Belinostat, Cisplatin, Etoposide
Advanced Pheochromocytoma and ParagangliomaFase 2NCT07282587
ONC206, ONC206: Dose 1, ONC206: Dose 2
PheochromocytomaFase 2NCT03206060Artículos
Lu-177-DOTATATE, Ga-68-DOTATATE
Pheochromocytoma/ParagangliomaFase 2NCT04924075Artículos
Belzutifan
Thyroid CancerFase 2NCT06007924
Avutometinib, Defactinib
High Grade Neuroendocrine NeoplasmsFase 2NCT06926634
Zanzalintinib
Neuroendocrine Tumor Grade 2Fase 2NCT04339036Artículos
Capecitabine Oral Product, Temozolomide Oral Product, transarterial radioembolization
Locally Advanced Adrenal Cortical CarcinomaFase 2NCT06900595
Biospecimen Collection, Cabozantinib, Cemiplimab, Computed Tomography
Neoadjuvant TreatmentFase 2NCT06959511
Zanzalintinib
Metastatic Thyroid CancerFase 2NCT03099356
Cyclophosphamide, Sirolimus
Differentiated Thyroid CancerFase 2NCT06458036
Selpercatinib Monotherapy, 131I Therapy
Locally Advanced Differentiated Thyroid Gland CarcinomaFase 2NCT06959641
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Survey Administration